FDA Approves First Treatment for Ebola
On October 14, through immediate press-release FDA (Food and Druf Administration of U.S.) approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies,…
Medications
Bonum Health Drug Savings With Singlecare
Recently Bonum Health announced about their partnership with Singlecare, for prescription saving. On October 13, Trxade Group Inc., an integrated drug procurement, delivery and healthcare…
Walgreens Launches Find Rx Coverage Advisor
On October 8th, Walgreens drugstore chain announced, Find Rx Coverage Advisor to support patients in maintaining affordable access to medications as health insurance shifts for…
Acella Recalls Thyroid Medications
Acella Pharmaceuticals, LLC recalls recalling one lot of 15-mg and one lot of 120-mg NP Thyroid, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to…
Hikma Launches Azacitidine
On September 10, Hikma Pharmaceuticals PLC (Hikma), at London announced Azacitidine for Injection, 100 mg, the generic version of Vidaza, in the United States it…
FDA Approval For RET Cancer Drug Gavreto
Recently FDA Okayed Gavreto (pralsetinib) for the treatment of adults with metastatic RET fusion-positive non-small cell lung cancer. Gavreto approved under the FDA’s accelerated approval…
No Link Between Antihypertensive and Cancer Risk
According to the press release from ESC (European Society of Cardiology), there is no evidence that blood pressure lowering drugs (antihypertensive as an example) increase…
Dapagliflozin Reduces Risk of Kidney Failure
Recently was confirmed, that treatment with dapagliflozin (Farxiga; AstraZeneca) reduced the risk of kidney failure and cardiovascular (CV) or renal death in patients with chronic…
ESC: Vascepa Reduces Patients’ Arterial Plaque
According to the information from the European Society of Cardiology’s (ESC) virtual annual meeting, which was at August 29 Vascepa cut patients’ coronary plaque by…
FDA Balks At Bayshore Recall
After the information from FDA about Bayshore Pharmaceuticals, LLC recall. It was a voluntary nationwide Bayshore recall of metformin hydrochloride extended-release tablets. The FDA begins…